# Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH

> **NCT01518166** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 70 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** liraglutide
- **DRUG:** placebo
- **DRUG:** atorvastatin
- **DRUG:** lisinopril
- **DRUG:** griseofulvin
- **DRUG:** digoxin

## Key facts

- **NCT ID:** NCT01518166
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518166, "Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01518166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*